Nervous System Channel
Topics
Medications
Quicklinks
Related Channels
 

Rasagiline

Rasagiline is a prescription drug licensed for the treatment of Parkinson's disease. By inhibiting MAO enzymes, the medication helps increase the amount of dopamine that the brain can use, which helps relieve symptoms of Parkinson's. Rasagiline comes in tablet form and is generally taken once a day. Common side effects include joint pain, headaches, and indigestion or heartburn.

Interested in a Discount on Rasagiline?

Enter your email address to see if eMedTV's free DiscountRx service has a program that could help you save on your prescription(s).

Enter Your Email Address
 

Thank you!

Thank you for your interest in DiscountRx from eMedTV. An email has been sent to the address you provided. Please follow the link within that email to see what offers may be available.

What Is Rasagiline?

Rasagiline mesylate (Azilect®) is a prescription medication approved to treat Parkinson's disease. It can be used alone or in combination with carbidopa-levodopa medications (such as Sinemet®, Sinemet® CR, Parcopa®, or Stalevo®).
 
(Click What Is Rasagiline Used For? for more information, including possible off-label uses.)
 

Rasagiline Side Effects

As with any medicine, side effects are possible with rasagiline. Although some side effects may be merely bothersome, others are quite serious or intolerable. Side effects often limit the usefulness of rasagiline.
 
Common side effects include but are not limited to:
 
(Click Side Effects of Rasagiline to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
 

Rasagiline Mesylate Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2013 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.